• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国儿童和青少年中抗甲型肝炎病毒抗体的流行率。

Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany.

机构信息

Institute of Virology and Antiviral Therapy, Jena University Clinic, Friedrich Schiller University of Jena, Hans-Knoell-Straße 2, 07745, Jena, Germany.

出版信息

Med Microbiol Immunol. 2013 Dec;202(6):417-24. doi: 10.1007/s00430-013-0303-4. Epub 2013 Jun 29.

DOI:10.1007/s00430-013-0303-4
PMID:23812435
Abstract

Since hepatitis A virus (HAV) infection during childhood is mostly asymptomatic, only seroprevalence studies can provide reliable information on incidence of HAV infection in children. The prevalence of anti-HAV antibodies was determined in sera taken in 2008 to 2010 from 1,645 children aged 0-17 years and in sera taken in 2010-2011 from 400 adult blood donors in Germany. For examination of trend over time, 715 sera collected between 1999 and 2006 from children at the age of 0-17 years within the federal state Thuringia were included. Antibody testing was carried out using the test kits ETI-AB-HAVK PLUS and ETI-HA-IGMK PLUS from DiaSorin. In children, the overall prevalence of antibodies was 10.8 %. After the seroprevalence declined from 8.8 % among the 0-2 year-olds to 2.4 % among the 3-4 year-olds, there was a significant increase to 20.5 % in the group of the 15-17 year-olds. Boys had with 12.7 % a significantly higher seroprevalence of anti-HAV antibodies compared to 8.8 % among girls. In adult blood donors, there was a HAV seroprevalence of 19.3 %. The likelihood of past infection or immunization within the age groups of children from 0 to 12 years differed significantly from that of adults. In conclusion, in Germany, only a small number of HAV infections occur in children, especially up to the age of 12 years. The proportion of susceptible children is greater than the proportion of susceptible adults. Thus, during outbreaks, the rate of infection among children would usually be higher than the rate among adults.

摘要

由于儿童时期甲型肝炎病毒(HAV)感染大多无症状,只有血清流行率研究才能提供有关儿童 HAV 感染发生率的可靠信息。在德国,2008 年至 2010 年期间,从 1645 名 0-17 岁儿童的血清中,以及 2010 年至 2011 年期间从 400 名成年献血者的血清中,确定了抗 HAV 抗体的流行率。为了考察随时间推移的趋势,纳入了 715 份 1999 年至 2006 年期间在图林根州 0-17 岁儿童中采集的血清。抗体检测使用 DiaSorin 的 ETI-AB-HAVK PLUS 和 ETI-HA-IGMK PLUS 试剂盒进行。在儿童中,抗体的总体流行率为 10.8%。在血清流行率从 0-2 岁儿童的 8.8%下降到 3-4 岁儿童的 2.4%之后,15-17 岁儿童组的流行率显著上升至 20.5%。男孩的抗 HAV 抗体血清流行率为 12.7%,明显高于女孩的 8.8%。在成年献血者中,HAV 的血清流行率为 19.3%。0-12 岁儿童组与成年组之间过去感染或免疫的可能性存在显著差异。总之,在德国,儿童中 HAV 感染的人数很少,尤其是在 12 岁以下。易感儿童的比例大于易感成人的比例。因此,在疫情爆发期间,儿童的感染率通常会高于成人。

相似文献

1
Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany.德国儿童和青少年中抗甲型肝炎病毒抗体的流行率。
Med Microbiol Immunol. 2013 Dec;202(6):417-24. doi: 10.1007/s00430-013-0303-4. Epub 2013 Jun 29.
2
Changing epidemiology of hepatitis A infection in Izmir, Turkey.土耳其伊兹密尔地区甲型肝炎感染的流行情况变化。
Vaccine. 2011 Aug 26;29(37):6259-61. doi: 10.1016/j.vaccine.2011.06.069. Epub 2011 Jul 18.
3
Changing epidemiological characteristics of Hepatitis A and warning of Anti-HAV immunity in Beijing, China: a comparison of prevalence from 1990 to 2017.中国北京甲型肝炎的流行特征变化及抗-HAV 免疫情况的警示:1990 年至 2017 年流行率比较。
Hum Vaccin Immunother. 2019;15(2):420-425. doi: 10.1080/21645515.2018.1529128. Epub 2018 Oct 12.
4
Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.印度海得拉巴市甲型肝炎病毒抗体的年龄相关血清流行率。
Trop Gastroenterol. 2000 Apr-Jun;21(2):63-5.
5
Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.在墨西哥进行的一项横断面研究中甲型肝炎病毒的血清流行率:对甲型肝炎疫苗接种的影响。
Hum Vaccin Immunother. 2013 Feb;9(2):375-81. doi: 10.4161/hv.22774. Epub 2013 Jan 4.
6
Hepatitis a in Lebanon: a changing epidemiological pattern.黎巴嫩的甲型肝炎:不断变化的流行病学模式。
Am J Trop Med Hyg. 2005 Aug;73(2):453-6.
7
Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.沙特阿拉伯西部学龄儿童中抗乙肝和抗甲肝抗体的流行情况。
Saudi Med J. 2006 Oct;27(10):1515-22.
8
Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea.2001年至2013年间甲型肝炎病毒IgG抗体血清流行率的变化:韩国某单一中心的经验
Clin Mol Hepatol. 2014 Jun;20(2):162-7. doi: 10.3350/cmh.2014.20.2.162. Epub 2014 Jun 30.
9
Seroprevalence of hepatitis A virus antibody in a population aged 0-30 years in Shanghai, China: implications for hepatitis A immunization.中国上海 0-30 岁人群甲型肝炎病毒抗体的血清流行率:甲型肝炎免疫接种的意义。
Epidemiol Infect. 2013 Mar;141(3):556-62. doi: 10.1017/S0950268812001161. Epub 2012 Jun 12.
10
[Hepatitis A immunity in refugees in Germany during the current exodus].[当前难民潮期间德国难民的甲型肝炎免疫力]
Med Klin Intensivmed Notfmed. 2017 May;112(4):347-351. doi: 10.1007/s00063-016-0203-7. Epub 2016 Jul 25.

引用本文的文献

1
Hepatitis A virus infections, immunisations and demographic determinants in children and adolescents, Germany.德国儿童和青少年甲型肝炎病毒感染、免疫接种和人口统计学决定因素。
Sci Rep. 2018 Nov 12;8(1):16696. doi: 10.1038/s41598-018-34927-1.
2
Seropositivity of Hepatitis A in Children Aged 7-14 Years in Diyarbakir Province Center.迪亚巴克尔省中心 7-14 岁儿童甲型肝炎血清阳性率。
Med Sci Monit. 2018 Feb 15;24:936-943. doi: 10.12659/msm.906861.
3
Seroprevalence of hepatitis a and associated factors among 1-15 year old children in Eastern Turkey.

本文引用的文献

1
Multiple factors contribute to positive results for hepatitis A virus immunoglobulin M antibody.多种因素导致甲型肝炎病毒免疫球蛋白 M 抗体呈阳性结果。
Arch Pathol Lab Med. 2013 Jan;137(1):90-5. doi: 10.5858/arpa.2011-0693-OA.
2
Impact of travel on the seroprevalence of hepatitis A in children.旅行对儿童甲型肝炎血清流行率的影响。
J Clin Virol. 2013 Jan;56(1):46-51. doi: 10.1016/j.jcv.2012.10.004. Epub 2012 Nov 3.
3
Clinical course and management of acute hepatitis A infection in adults.成人急性甲型肝炎感染的临床病程和管理。
土耳其东部1至15岁儿童甲型肝炎血清流行率及相关因素
Int J Clin Exp Med. 2015 Oct 15;8(10):19394-9. eCollection 2015.
4
Vaccination against infectious diseases: what is promising?传染病疫苗接种:有哪些有前景的疫苗?
Med Microbiol Immunol. 2014 Dec;203(6):365-71. doi: 10.1007/s00430-014-0346-1. Epub 2014 Jul 27.
5
Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany.德国生猪高密度养殖地区人群中戊型肝炎病毒(HEV)的血清流行率。
Med Microbiol Immunol. 2014 Aug;203(4):273-82. doi: 10.1007/s00430-014-0336-3. Epub 2014 Apr 18.
6
Prevalence of antibodies to European porcine influenza viruses in humans living in high pig density areas of Germany.居住在德国生猪高密度地区人群中针对欧洲猪流感病毒抗体的流行率。
Med Microbiol Immunol. 2014 Feb;203(1):13-24. doi: 10.1007/s00430-013-0309-y. Epub 2013 Sep 8.
Ann Hepatol. 2012 Sep-Oct;11(5):652-7.
4
WHO position paper on hepatitis A vaccines – June 2012.世界卫生组织关于甲型肝炎疫苗的立场文件——2012年6月
Wkly Epidemiol Rec. 2012 Jul 13;87(28/29):261–76.
5
Changes in seroprevalence to hepatitis A in Victoria, Australia: a comparison of three time points.澳大利亚维多利亚州甲型肝炎血清流行率的变化:三个时间点的比较。
Vaccine. 2012 Sep 14;30(42):6020-6. doi: 10.1016/j.vaccine.2012.07.058. Epub 2012 Aug 3.
6
Comparative hepatitis A seroepidemiology in 10 European countries.10 个欧洲国家甲型肝炎血清流行病学比较。
Epidemiol Infect. 2012 Dec;140(12):2172-81. doi: 10.1017/S0950268812000015. Epub 2012 Jan 25.
7
Changing epidemiological patterns of hepatitis A infection in Singapore.新加坡甲型肝炎感染的流行病学模式变化。
Ann Acad Med Singap. 2011 Oct;40(10):439-47.
8
Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006.德国图林根州 1999 年至 2006 年单纯疱疹病毒 1 型和 2 型的血清流行率。
Euro Surveill. 2011 Nov 3;16(44):20005.
9
Challenges to mapping the health risk of hepatitis A virus infection.甲型肝炎病毒感染的健康风险映射面临的挑战。
Int J Health Geogr. 2011 Oct 18;10:57. doi: 10.1186/1476-072X-10-57.
10
Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany.德国<18 岁儿童中甲型流感 A(H1N1)2009 大流行感染(猪流感)的大流行后血清流行率。
PLoS One. 2011;6(9):e23955. doi: 10.1371/journal.pone.0023955. Epub 2011 Sep 7.